Qualtec Co

Qualtec Co Retained Earnings

The Retained Earnings of Qualtec Co (9165.T) as of Nov 3, 2026 is 2.08 B JPY. In the previous year, Retained Earnings was 1.82 B JPY — a change of 14.36% (higher).

Retained Earnings

2.08 BJPY

YoY

14.36%

Last updated:

Retained Earnings of Qualtec Co is 2026 2.08 B JPY. Retained Earnings of Qualtec Co was 2025 1.82 B JPY. It decreases by 14.36% higher compared to the previous year.

The Qualtec Co Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2021
1.05 B JPY
Jan 1, 2022
1.37 B JPY
Jan 1, 2023
1.50 B JPY
Jan 1, 2024
1.70 B JPY
Jan 1, 2025
1.82 B JPY
Jan 1, 2026
2.08 B JPY
The Qualtec Co Retained Earnings history
YEARRetained EarningsYoY
2.08 BJPY+14.36%
1.82 BJPY+7.14%
1.70 BJPY+12.78%
1.50 BJPY+9.64%
1.37 BJPY+31.33%
1.05 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Qualtec Co Stock analysis

What does Qualtec Co do? Qualtec Co Ltd generates revenue through three business segments. The Reliability Evaluation Business segment sells testing machines and provides environmental, electrical, and vibration tests, including non-defective and defective product analysis. The Microfabrication Business segment offers laser processing services for build-up boards and flexible printed boards in both prototype and mass production. The Other Business segment delivers genetic mutation detection services for pets, contracted biomedical testing for packaging materials and syringes, and zero innovation consulting services. These services target industrial clients, veterinary clinics, and biomedical companies. The company's Reliability Evaluation segment serves manufacturers requiring product reliability validation. The Microfabrication segment caters to electronics manufacturers needing laser processing for circuit boards. The genetic testing services in the Other Business segment are sold to pet owners and veterinary clinics. Biomedical testing services target companies in the medical device industry. Zero innovation consulting is offered to businesses seeking technology and surface treatment solutions. Qualtec's product portfolio includes testing machines, laser processing services, genetic mutation detection, biomedical testing, and consulting services. The company's primary customers are electronics manufacturers, biomedical firms, veterinary clinics, and pet owners. These segments collectively serve industrial and healthcare markets with specialized technical services. Qualtec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qualtec Co stock

Retained Earnings of Qualtec Co is 2.08 B JPY in 2026.

Retained Earnings of Qualtec Co changed from 1.82 B JPY to 2.08 B JPY, representing a 14.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Qualtec Co since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Qualtec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Qualtec Co

All Key Metrics — Qualtec Co